Managing active iupus nephritis during COVID-19 pandemic

Managing active iupus nephritis during COVID-19 pandemic

India is seeing a rapid rise in coronavirus disease-2019 (COVID-19). Immunosuppression is a possible risk factor for severe COVID-19, although their exact interaction is unclear. A total of 13 cases with active lupus nephritis (LN, with or without extra-renal manifestations) were managed with intens...

Full description

Bibliographic Details
Main Authors: Joyita Bharati, Manish Rathi, Raja Ramachandran, Aman Sharma, Ritambhra Nada, Harbir S Kohli
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Indian Journal of Nephrology
Subjects:
covid-19
flare
hydroxychloroquine
immunosuppression
lupus nephritis
systemic lupus erythematosus
Online Access:http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2021;volume=31;issue=4;spage=390;epage=393;aulast=Bharati

Internet

http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2021;volume=31;issue=4;spage=390;epage=393;aulast=Bharati

Similar Items